High-density lipoprotein: epidemiology, metabolism, and antiatherogenic effects.
Toth
P P
PP
Sterling Rock Falls Clinic, Southern Illinois University School of Medicine, USA.
D016632:Apolipoprotein A-I / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000097:blood / Q000453:epidemiology; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008075:Lipoproteins, HDL / Q000097:blood / Q000378:metabolism / Q000502:physiology; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
D016632:Apolipoprotein A-I; D000960:Hypolipidemic Agents; D008075:Lipoproteins, HDL; D002784:Cholesterol